VEGFA and acute myeloid leukemia: Between 2001 and 2004, four clinical trials (NCT00022048, NCT00015951, NCT00096148, and NCT00023920) assessed the effects of bevacizumab in R/R AML and MDS, but currently, there are no active clinical trials on anti-VEGF mAb therapy in AML or MDS.